ArticleGenetics in medicine open2025
Patient and providers' perspectives on using the GUÍA digital tool to enhance genomic results disclosure.
Article in Genetics in medicine open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
Abstract
Purpose: Genomic testing is expanding, yet disparities persist in result disclosure, particularly among diverse and bilingual populations. The Genomic Understanding, Information, and Awareness (GUÍA) digital tool was developed to enhance genomic results communication for parents of children undergoing genomic testing. This study evaluates the effectiveness of GUÍA from both patient and provider perspectives. Methods: Participants were enrolled in the NYCKidSeq and TeleKidSeq studies, which randomized families to standard genetic counseling or GUÍA-assisted result disclosure. Surveys assessed parents' satisfaction with and perceived effectiveness of GUÍA, and their use of GUÍA after disclosure. Genetic counselors were surveyed on usability and integration into clinical workflows. Statistical analyses explored demographic and linguistic factors influencing perceived effectiveness. Results: Of 375 participants, 91% found the information provided by GUÍA "just right," 87% were very satisfied with materials, and 91% reported that GUÍA was helpful in explaining their child's results. GUÍA facilitated communication, with 37% using it to explain results to family and 34% to providers. Genetic counselors reported high usability and minimal burden. Spanish-speaking participants reported greater perceived effectiveness, highlighting its role in addressing linguistic barriers. Conclusion: GUÍA enhances genomic results communication, improves patient understanding, and supports equitable genetic counseling. Its structured, bilingual approach may serve as a scalable model for improving result disclosure in diverse populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.